Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Hum Mol Genet ; 22(9): 1746-54, 2013 May 01.
Artigo em Inglês | MEDLINE | ID: mdl-23359570

RESUMO

Several known or putative glycosyltransferases are required for the synthesis of laminin-binding glycans on alpha-dystroglycan (αDG), including POMT1, POMT2, POMGnT1, LARGE, Fukutin, FKRP, ISPD and GTDC2. Mutations in these glycosyltransferase genes result in defective αDG glycosylation and reduced ligand binding by αDG causing a clinically heterogeneous group of congenital muscular dystrophies, commonly referred to as dystroglycanopathies. The most severe clinical form, Walker-Warburg syndrome (WWS), is characterized by congenital muscular dystrophy and severe neurological and ophthalmological defects. Here, we report two homozygous missense mutations in the ß-1,3-N-acetylglucosaminyltransferase 1 (B3GNT1) gene in a family affected with WWS. Functional studies confirmed the pathogenicity of the mutations. First, expression of wild-type but not mutant B3GNT1 in human prostate cancer (PC3) cells led to increased levels of αDG glycosylation. Second, morpholino knockdown of the zebrafish b3gnt1 orthologue caused characteristic muscular defects and reduced αDG glycosylation. These functional studies identify an important role of B3GNT1 in the synthesis of the uncharacterized laminin-binding glycan of αDG and implicate B3GNT1 as a novel causative gene for WWS.


Assuntos
Mutação de Sentido Incorreto , N-Acetilglucosaminiltransferases/genética , Síndrome de Walker-Warburg/genética , Animais , Linhagem Celular Tumoral , Mapeamento Cromossômico , Estudos de Coortes , Distroglicanas/metabolismo , Feminino , Regulação da Expressão Gênica , Técnicas de Silenciamento de Genes , Glicosilação , Homozigoto , Humanos , Lactente , Laminina/metabolismo , Masculino , Distrofia Muscular do Cíngulo dos Membros/genética , N-Acetilglucosaminiltransferases/metabolismo , Linhagem , Fenótipo , Ligação Proteica , Síndrome de Walker-Warburg/patologia , Peixe-Zebra/genética
2.
Nat Genet ; 44(5): 581-5, 2012 May.
Artigo em Inglês | MEDLINE | ID: mdl-22522421

RESUMO

Walker-Warburg syndrome (WWS) is an autosomal recessive multisystem disorder characterized by complex eye and brain abnormalities with congenital muscular dystrophy (CMD) and aberrant a-dystroglycan glycosylation. Here we report mutations in the ISPD gene (encoding isoprenoid synthase domain containing) as the second most common cause of WWS. Bacterial IspD is a nucleotidyl transferase belonging to a large glycosyltransferase family, but the role of the orthologous protein in chordates is obscure to date, as this phylum does not have the corresponding non-mevalonate isoprenoid biosynthesis pathway. Knockdown of ispd in zebrafish recapitulates the human WWS phenotype with hydrocephalus, reduced eye size, muscle degeneration and hypoglycosylated a-dystroglycan. These results implicate ISPD in a-dystroglycan glycosylation in maintaining sarcolemma integrity in vertebrates.


Assuntos
Distroglicanas/metabolismo , Mutação/genética , Síndrome de Walker-Warburg/genética , Peixe-Zebra/genética , Animais , Encéfalo/metabolismo , Encéfalo/patologia , Pré-Escolar , Embrião não Mamífero , Olho/metabolismo , Olho/patologia , Glicosilação , Humanos , Manosiltransferases/genética , Manosiltransferases/metabolismo , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patologia , Peixe-Zebra/embriologia
3.
Am J Hum Genet ; 85(1): 76-86, 2009 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-19576565

RESUMO

Alpha-dystroglycanopathies such as Walker Warburg syndrome represent an important subgroup of the muscular dystrophies that have been related to defective O-mannosylation of alpha-dystroglycan. In many patients, the underlying genetic etiology remains unsolved. Isolated muscular dystrophy has not been described in the congenital disorders of glycosylation (CDG) caused by N-linked protein glycosylation defects. Here, we present a genetic N-glycosylation disorder with muscular dystrophy in the group of CDG type I. Extensive biochemical investigations revealed a strongly reduced dolichol-phosphate-mannose (Dol-P-Man) synthase activity. Sequencing of the three DPM subunits and complementation of DPM3-deficient CHO2.38 cells showed a pathogenic p.L85S missense mutation in the strongly conserved coiled-coil domain of DPM3 that tethers catalytic DPM1 to the ER membrane. Cotransfection experiments in CHO cells showed a reduced binding capacity of DPM3(L85S) for DPM1. Investigation of the four Dol-P-Man-dependent glycosylation pathways in the ER revealed strongly reduced O-mannosylation of alpha-dystroglycan in a muscle biopsy, thereby explaining the clinical phenotype of muscular dystrophy. This mild Dol-P-Man biosynthesis defect due to DPM3 mutations is a cause for alpha-dystroglycanopathy, thereby bridging the congenital disorders of glycosylation with the dystroglycanopathies.


Assuntos
Dolicol Monofosfato Manose/metabolismo , Manosiltransferases/genética , Proteínas de Membrana/genética , Distrofias Musculares/genética , Distrofias Musculares/metabolismo , Distroglicanas/metabolismo , Feminino , Glicosilação , Humanos
4.
Eur J Hum Genet ; 15(2): 155-61, 2007 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-17106447

RESUMO

The m.13513G > A transition in the mitochondrial gene encoding the ND5 subunit of respiratory chain complex I, can cause mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes (MELAS) and has been reported to be a frequent cause of Leigh syndrome (LS). We determined the frequency of the mutation in a cohort of 123 patients with reduced complex I activity in muscle (n = 113) or fibroblast (n = 10) tissue. We describe a Pyrosequencing assay for rapid detection and quantification of the m.13513G > A mutation. Two patients with the mutation were identified; both had LS, optical atrophy and a Wolff-Parkinson-White Syndrome (WPWS)-like cardiac conduction defect. The clinical presentation of the m.13513G > A mutation is discussed. We conclude that the m.13513G > A mutation seems not as frequent as previously suggested and is most likely to be present in patients with Leigh (-like) syndrome combined with a complex I deficiency, optic atrophy and/ or WPWS. In addition, we confirmed that the adjacent m.13514A > G mutation is a rare cause of LS or MELAS since no cases with this transition were found.


Assuntos
Complexo I de Transporte de Elétrons/análise , Doença de Leigh/genética , Proteínas Mitocondriais/genética , Atrofia Óptica/genética , Síndrome de Wolff-Parkinson-White/genética , Estudos de Coortes , Análise Mutacional de DNA/métodos , DNA Mitocondrial/genética , Complexo I de Transporte de Elétrons/genética , Feminino , Frequência do Gene , Humanos , Doença de Leigh/complicações , Doença de Leigh/enzimologia , Masculino , Músculo Esquelético/enzimologia , Mutação , Atrofia Óptica/complicações , Atrofia Óptica/enzimologia , Síndrome de Wolff-Parkinson-White/complicações , Síndrome de Wolff-Parkinson-White/enzimologia
5.
Neuromuscul Disord ; 16(8): 510-3, 2006 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-16919950

RESUMO

Recognizing an ALS-mimic can be challenging. Here, we describe a patient with a slowly progressive dysarthria and dysphagia, with fasciculations of the tongue and general hyperreflexia, fulfilling the diagnostic criteria of 'clinical probable ALS'. Because of a non-conclusive EMG, a muscle biopsy was performed that surprisingly showed widespread nemaline rods. The clinical features and the histological findings were compatible with a sporadic late onset nemaline myopathy. Three years after initial presentation the patient died and post-mortem examination not only showed nemaline bodies in every muscle examined, but also revealed an unsuspected final diagnosis: sarcoid brainstem encephalitis. Nemaline rods can be found in various disorders, and neurosarcoidosis should be added to this list.


Assuntos
Tronco Encefálico/patologia , Erros de Diagnóstico/prevenção & controle , Encefalite/complicações , Músculo Esquelético/patologia , Miopatias da Nemalina/complicações , Sarcoidose/complicações , Esclerose Lateral Amiotrófica/diagnóstico , Esclerose Lateral Amiotrófica/fisiopatologia , Biópsia , Tronco Encefálico/fisiopatologia , Diagnóstico Diferencial , Encefalite/diagnóstico , Encefalite/fisiopatologia , Evolução Fatal , Feminino , Granuloma/patologia , Humanos , Corpos de Inclusão/metabolismo , Corpos de Inclusão/patologia , Pessoa de Meia-Idade , Fibras Musculares Esqueléticas/metabolismo , Fibras Musculares Esqueléticas/patologia , Músculo Esquelético/fisiopatologia , Miopatias da Nemalina/diagnóstico , Miopatias da Nemalina/fisiopatologia , Neurônios/metabolismo , Neurônios/patologia , Sarcoidose/diagnóstico , Sarcoidose/fisiopatologia
6.
Hum Mutat ; 27(5): 453-9, 2006 May.
Artigo em Inglês | MEDLINE | ID: mdl-16575835

RESUMO

The importance of O-glycosylation of alpha-dystroglycan (alpha-DG) is evident from the identification of POMT1 mutations in Walker-Warburg syndrome (WWS). Approximately one-fifth of the WWS patients show mutations in POMT1, which result in complete loss of protein mannosyltransferase activity. WWS patients are characterized by congenital muscular dystrophy (CMD) with severe brain and eye abnormalities. This suggests a crucial role for alpha-DG during development of these organs and tissues. Here we report new POMT1 mutations and polymorphisms in WWS patients. In addition, we report different compound heterozygous POMT1 mutations in four unrelated families that result in a less severe phenotype than WWS, characterized by CMD with calf hypertrophy, microcephaly, and mental retardation. Compared to WWS patients, these patients have milder structural brain abnormalities, and eye abnormalities were absent, except for myopia in some cases. In these patients we postulate that one or both transcripts for POMT1 confer residual protein O-mannosyltransferase activity. Our data suggest the existence of a disease spectrum of CMD including brain and eye abnormalities resulting from POMT1 mutations.


Assuntos
Deficiência Intelectual/genética , Manosiltransferases/genética , Microcefalia/genética , Distrofias Musculares/genética , Mutação , Adolescente , Encéfalo/anormalidades , Encéfalo/patologia , Pré-Escolar , Mapeamento Cromossômico , Análise Mutacional de DNA , Distroglicanas/genética , Distroglicanas/metabolismo , Anormalidades do Olho/genética , Feminino , Humanos , Deficiência Intelectual/diagnóstico , Deficiência Intelectual/patologia , Masculino , Manosiltransferases/metabolismo , Microcefalia/diagnóstico , Microcefalia/patologia , Repetições de Microssatélites , Distrofias Musculares/diagnóstico , Distrofias Musculares/patologia , Fenótipo , Polimorfismo Genético , Síndrome
7.
J Virol Methods ; 117(2): 179-87, 2004 May.
Artigo em Inglês | MEDLINE | ID: mdl-15041215

RESUMO

The potency of live attenuated virus vaccines is determined by counting or titrating viable viruses in cell cultures. These classical potency tests have the drawback that they are time consuming and laborious and show a high laboratory-to-laboratory variation. In the present study we describe the development and validation of a fast method to measure the potency of measles in trivalent measles, mumps and rubella (MMR) vaccines using quantitative real-time PCR (qPCR). Vero cells were infected with serial dilutions of a trivalent vaccine or a trivalent reference with known potency. Virus was allowed to replicate and subsequently replicated virus was quantitated by qPCR using the LightCycler technology. The virus titer in vaccine samples was estimated against reference preparations using parallel line analysis. In comparison to the plaque assay, the qPCR infectivity assay was faster and less laborious, while accuracy and intermediate precision were similar.


Assuntos
Vacina contra Sarampo/análise , Vírus do Sarampo/isolamento & purificação , Animais , Chlorocebus aethiops , Vírus do Sarampo/genética , Vírus do Sarampo/fisiologia , Reação em Cadeia da Polimerase/métodos , Reprodutibilidade dos Testes , Reação em Cadeia da Polimerase Via Transcriptase Reversa/métodos , Células Vero , Ensaio de Placa Viral , Replicação Viral/fisiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...